Testing JL18008 for HIV Patients Not Recovering Immune Cells
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study tests an experimental drug called JL18008 in people with HIV who have been on stable HIV medications for years but whose immune systems (CD4 cells) haven't recovered as expected. The drug may help boost immune function in these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 and healthy weight (BMI 18–32)
- On HIV medications for at least 4 years with stable regimen for 3+ months
- HIV viral load undetectable (below 50 copies/mL) for at least 3 years
- CD4 count (immune cell count) persistently low at 350 or below despite long-term treatment
- No recent infections, autoimmune disease, or serious heart/liver/kidney problems
- Willing to use contraception and commit to study visits for several months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This study tests new treatments to help people with HIV who have low CD4 counts despite antiretroviral therapy. It aims to improve immune function and reduce the risk of infections.
This trial tests a new injectable treatment called LP-98 for people with HIV who have never taken HIV medications before. It aims to see if the drug is safe and can help lower the virus in your body.
This study tests a medicine called IL-7 (interleukin-7) that may help raise the number of CD4 cells (a type of immune cell) in people with HIV whose CD4 counts stay low despite effective HIV treatment. The goal is to see if it can improve immune function and potentially reduce infection risk.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.